Lafora's disease

1974 ◽  
Vol 30 (3) ◽  
pp. 189-196 ◽  
Author(s):  
S. Ram�n y Cajal ◽  
A. Blanes ◽  
A. Martinez ◽  
E. S�enz ◽  
M. Gutierrez
Keyword(s):  
1990 ◽  
Vol 38 (2) ◽  
pp. 75-79 ◽  
Author(s):  
Zijian Jian ◽  
M.R. Alley ◽  
Juliet Cayzer ◽  
G.R. Swinney
Keyword(s):  

2007 ◽  
Vol 10 (5) ◽  
pp. 351-357 ◽  
Author(s):  
Anne-Marie O'Shea ◽  
Gregory J. Wilson ◽  
Simon C. Ling ◽  
Berge A. Minassian ◽  
Julie Turnbull ◽  
...  

We report 2 cases of ground-glass hepatocyte inclusions occurring in pediatric patients. Case 1 had alpha-thalassaemia major and was receiving iron chelation therapy, whereas case 2 had trisomy 21 with a history of bone marrow transplantation for acute myeloid leukemia. The liver sections in both cases showed eosinophilic, periodic acid-Schiff diastase—positive intracytoplasmic inclusions that were negative for hepatitis B surface antigen. Immunohistochemically the inclusions showed positive staining with KM279, a monoclonal antibody against polyglucosan derived from Lafora inclusions. On electron microscopy, in case 1, intracytoplasmic inclusions were composed of degenerate organelles, glycogen, and irregular fibrillar structures; in case 2, they were composed of vesicular structures containing granular material. Ultrastructural changes in both cases differed from classical Lafora inclusions and ruled out hepatitis B surface antigen, glycogenosis type IV, and fibrinogen storage disease. Genetic analysis of the Lafora's disease genes performed in case 2 revealed no mutations. The development of hepatocyte cytoplasmic inclusions in both our cases could be related to medication effects, because similar inclusions were reported in patients using cyanamide. Drug-induced inclusions, mimicking Lafora's disease, should be included in the differential diagnosis of hepatocyte ground-glass inclusions.


1986 ◽  
Vol 43 (3) ◽  
pp. 296 ◽  
Author(s):  
Bert L. S. M. Busard
Keyword(s):  

Neurology ◽  
1967 ◽  
Vol 17 (5) ◽  
pp. 502-502 ◽  
Author(s):  
J.-L. Riehl ◽  
D. K. Lee ◽  
J. M. Andrews ◽  
W. J. Brown
Keyword(s):  

1987 ◽  
Vol 21 (6) ◽  
pp. 599-601 ◽  
Author(s):  
H. L. S. M. Busard ◽  
A. A. W. M. GabreëLs-Festen ◽  
W. O. Renier ◽  
F. J. M. Gabreës ◽  
A. M. Stadhouders

1990 ◽  
Vol 48 (2) ◽  
pp. 236-240 ◽  
Author(s):  
A. Cukiert ◽  
M.M. Vilela ◽  
H.B. Scapolan ◽  
B. H. W. Lefèvre ◽  
L. Marques-Assis

Lafora's disease is included among the progressive myoclonic epilepsies. Despite the fact that dementia is a constant finding in this disease only a few papers have studied the timing of riental deterioration. We have performed wide neuropsychological testing in two cases early diagnosed as Lafora disease. The initial neuropsychological testing was carried out by the time there were no complaints of mental deterioration in both cases. In the first case consecutive neuropsychological testing demonstrated the rapidly progressive dementia. All neuropsychological testings in these cases showed severe impairment of right parietal lobe functions. Higher cortical functions related to language and intelectual processes were beet preserved in both cases. The functions related to constructional praxis, memory and abstract concepts and processes were severily impaired. Our data suggest that mental deterioration is an early manifestation in Lafora disease, even by the time normal social life is not yet disturbed. Dominant hemisphere cognitivo functions have been less impaired than the non-dominant ones. How a diffuse illness such as Lafora disease can cause such an asymmetrical higher cortical function deficit is not yet clear.


Neurology ◽  
1993 ◽  
Vol 43 (6) ◽  
pp. 1246-1246 ◽  
Author(s):  
M. A. Kaufman ◽  
A. J. Dwork ◽  
N. J. Willson ◽  
S. John ◽  
J. D. Liu
Keyword(s):  

1989 ◽  
Vol 29 (6) ◽  
pp. 333-338 ◽  
Author(s):  
Pierre Genton ◽  
Michel Borg ◽  
Piernanda Vigliano ◽  
Jean-François Pellissier ◽  
Joseph Roger

1974 ◽  
Vol 52 (12) ◽  
pp. 559-567 ◽  
Author(s):  
H. Huchzermeyer ◽  
L. Gerhard
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document